← Leaderboards
So Eric
Pennsylvania State Univ Hershey Med Ctr
$1,000,366
Attributed
$2,000,732
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $520.3K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,000,732 · 1
By mechanism
R01$2,000,732 · 1
Top collaborators
- Suming Huang5 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Suming Huang$10,342,386
- Mingjiang Xu$9,383,816
- Karam E El-Bayoumy$14,292,983
- Yatin M Vyas$8,495,449
- Feng Yue$14,148,069
Others in their field
Other Rising Stars on “Acute Myelocytic Leukemia”
- Michael E. Roth · Public Health Institute$8,303,012
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myelocytic LeukemiaAdultBeta CateninAcute Myeloid Leukemia CellBiochemicalBiologicalBone Marrow FailureCancer Stem CellBindingCellsCohesinCohesionComplementComplexDegenerative DisorderDesignDna DamageDna RepairCell LineEnhancersEpigenetic ProcessFutureGain Of FunctionGene Regulatory Network
Grant awards (5)
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells$303,207
R01 · FY2025 · CA
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells$202,540
R01 · FY2025 · CA
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells$479,644
R01 · FY2024 · CA
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells$495,056
R01 · FY2023 · CA
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells$520,285
R01 · FY2022 · CA